MarketPeel
Insider Trading Intelligence
Pricing
…
SP

Shelly Pinto

ALXO
SVP, FINANCE AND CAO · ALX ONCOLOGY HOLDINGS INC · CIK 0001857740
FILING MIX · LIFETIME50%/50%
BUYS
16
SELLS
16
TOTAL VALUE
$106.2K
COMPANIES
1
ACTIVE SINCE
May 2020
HOLDINGS NOW
86,805
AVG SELL PX
$4.66
TRADE KIND
SHOWING 32 / 32
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
16 backtested trades · 8 horizons · 19 pending
Forward-return performance of every backtestable P/S trade by Shelly Pinto, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d16+43.75%+7.38%+0.03%+7.35%+3.23%—
14d16+56.25%+5.76%+0.43%+5.33%-4.13%—
30d16+62.50%+2.08%+1.21%+0.86%-15.84%—
60d16+62.50%+15.08%+2.40%+12.67%-31.29%—
90d16+75.00%+19.42%+3.56%+15.86%-38.54%—
180d16(3 pending)+69.23%+18.36%+9.97%+8.39%-71.64%—
1y16(5 pending)+72.73%+4.71%+19.90%-15.19%-56.22%—
2y16(11 pending)+100.00%-85.33%+46.94%-132.28%-138.55%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ALXO · 86,805 shares · as of Mar 19, 2026
048,00096,000144,000192,000202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 16 buys / 16 sellsCOVERAGE · 24 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ALXO
ALX ONCOLOGY HOLDINGS INC
SALE
SVP, FINANCE AND CAO
903$2.17$2.0K86,805Mar 19, 2026Mar 23, 2026 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
SALE
SVP, FINANCE AND CAO
565$2.27$1.3K87,708Feb 18, 2026Feb 20, 2026 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
192,000——192,000Jan 26, 2026Jan 28, 2026 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
SALE
SVP, FINANCE AND CAO
3,925$1.11$4.4K88,273Jan 6, 2026Jan 7, 2026 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
140,000——140,000Oct 14, 2025Oct 16, 2025 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
SALE
SVP, FINANCE AND CAO
611$0.64$39189,198Aug 15, 2025Aug 19, 2025 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
SALE
SVP, FINANCE AND CAO
2,011$0.45$90586,809Jul 7, 2025Jul 8, 2025 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
SALE
SVP, FINANCE AND CAO
1,532$0.43$65988,820Jun 30, 2025Jul 1, 2025 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
90,000——90,000Apr 11, 2025Apr 15, 2025 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
3,000——90,352Mar 14, 2025Mar 18, 2025 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
SALE
SVP, FINANCE AND CAO
550$1.15$63387,352Feb 19, 2025Feb 21, 2025 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
112,000——112,000Jan 21, 2025Jan 23, 2025 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
SALE
Interim CFO
2,221$1.80$4.0K87,902Jan 6, 2025Jan 8, 2025 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
SALE
Interim CFO
1,426$1.58$2.3K90,123Dec 30, 2024Jan 2, 2025 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
150,000——150,000Dec 2, 2024Dec 4, 2024 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
SALE
SVP, FINANCE AND CAO
564$2.58$1.5K91,549Aug 14, 2024Aug 16, 2024 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
SALE
SVP, FINANCE AND CAO
1,823$5.50$10.0K92,113Jul 5, 2024Jul 9, 2024 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
SALE
SVP, FINANCE AND CAO
1,373$5.82$8.0K93,936Jul 1, 2024Jul 3, 2024 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
15,000——93,591Feb 14, 2024Feb 16, 2024 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
35,000——35,000Feb 14, 2024Feb 16, 2024 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
SALE
SVP, Finance and CAO
2,717$13.60$37.0K78,591Jan 4, 2024Jan 5, 2024 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
SALE
SVP, Finance and CAO
1,631$15.04$24.5K81,308Dec 29, 2023Jan 3, 2024 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
26,000——81,713Jul 25, 2023Jul 27, 2023 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
36,000——36,000Jul 25, 2023Jul 27, 2023 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
SALE
VP, Finance and CAO
466$7.34$3.4K63,058Jun 30, 2023Jul 5, 2023 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
SALE
VP, Finance and CAO
482$11.07$5.3K62,097Dec 29, 2022Jan 3, 2023 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
11,000——62,718Aug 5, 2022Aug 9, 2022 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
36,000——36,000Aug 5, 2022Aug 9, 2022 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
50,000——50,446Jan 28, 2022Feb 1, 2022 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
25,000——25,000Jul 30, 2021Aug 3, 2021 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
125,000——125,000May 3, 2021May 19, 2021 ↗View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
125,000——125,000May 3, 2020May 5, 2021 ↗View →
Other insiders · ALXO
Loading peer insiders…
About this filer
CIK 0001857740
ROLE
SVP, FINANCE AND CAO
PRIMARY
ALXO
COMPANIES
1
ACTIVE SINCE
May 2020
MARKETPEEL · /INSIDER/0001857740DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback